News & Updates

Finerenone lowers CV risk in patients with CKD, T2D

12 Dec 2020 by

Treatment with finerenone led to significantly reduced risk of cardiovascular (CV) events in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), regardless of their CV disease (CVD) history, according to the FIDELIO-DKD* trial presented at AHA 2020.

Finerenone lowers CV risk in patients with CKD, T2D

12 Dec 2020

Finerenone reduces CKD progression, CV risk

11 Dec 2020 by

Treatment with the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone reduced chronic kidney disease (CKD) progression and cardiovascular (CV) event risk in patients with CKD and type 2 diabetes (T2D), according to the FIDELIO-DKD* study presented at ASN Kidney Week 2020.

Finerenone reduces CKD progression, CV risk

11 Dec 2020

High rice intake, traditional diet tied to lower CVD risk

10 Dec 2020

A prospective cohort study in China has shown that traditional dietary pattern and rice consumption are inversely related to cardiovascular disease (CVD) risk, while modern dietary pattern and wheat intake are directly associated.

High rice intake, traditional diet tied to lower CVD risk

10 Dec 2020

Lipid-lowering medication adherence may impact cancer-specific mortality

09 Dec 2020 by

Adherence to lipid-lowering medications (LLMs) prior and following cancer diagnosis may have bearing on cancer-specific mortality, according to a study from Australia.

Lipid-lowering medication adherence may impact cancer-specific mortality

09 Dec 2020

ACEI/ARBs do not induce in-hospital mortality in COVID-19 patients

09 Dec 2020 by

The use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) does not contribute to in-hospital mortality among patients with the novel coronavirus disease (COVID-19) and is safe in those with indications, suggests a Singapore study.

ACEI/ARBs do not induce in-hospital mortality in COVID-19 patients

09 Dec 2020

Alpha blockers in CKD patients cardioprotective but may accelerate disease progression

22 Oct 2020 by

Use of alpha blockers in patients with chronic kidney disease (CKD) appears to be both beneficial and detrimental, with a recent study linking it to lower risk of cardiac events and mortality but higher risk of kidney disease progression compared with alternative blood pressure-lowering medications.

Alpha blockers in CKD patients cardioprotective but may accelerate disease progression

22 Oct 2020

Reproductive health of young women linked to CVD in later life

22 Oct 2020 by

The reproductive profile of women from menarche to menopause contributes to their future risk of cardiovascular disease (CVD), suggests a recent study.

Reproductive health of young women linked to CVD in later life

22 Oct 2020

Plant protein intake tied to lower all-cause, CVD mortality risk

21 Oct 2020 by

Consumption of plant protein was associated with a lower risk of all-cause and cardiovascular disease (CVD) mortality, according to a systematic review and meta-analysis, suggesting that substituting foods high in animal protein with plant protein sources may correlate with longevity.

Plant protein intake tied to lower all-cause, CVD mortality risk

21 Oct 2020

Empagliflozin: Another SGLT-2i in HFrEF armamentarium

21 Oct 2020 by

Adding empagliflozin to recommended therapy in patients with heart failure with reduced ejection fraction (HFrEF) reduced the risk of HF hospitalization and slowed renal function decline, the EMPEROR-Reduced* trial showed.

Empagliflozin: Another SGLT-2i in HFrEF armamentarium

21 Oct 2020

DASH diet: Best nonpharmacological intervention for hypertension

21 Oct 2020

A new network meta-analysis shines a spotlight on the Dietary Approach to Stop Hypertension (DASH) diet as the most effective nondrug intervention to control blood pressure in adults with prehypertension to established hypertension. Interventions such as aerobic exercise, isometric training, salt restriction, breathing control, and meditation are also helpful.

DASH diet: Best nonpharmacological intervention for hypertension

21 Oct 2020

News & Updates

Filter by Specialty:

Specialty:

Finerenone lowers CV risk in patients with CKD, T2D

Finerenone lowers CV risk in patients with CKD, T2D

Finerenone reduces CKD progression, CV risk

Finerenone reduces CKD progression, CV risk

High rice intake, traditional diet tied to lower CVD risk

High rice intake, traditional diet tied to lower CVD risk

Lipid-lowering medication adherence may impact cancer-specific mortality

Lipid-lowering medication adherence may impact cancer-specific mortality

ACEI/ARBs do not induce in-hospital mortality in COVID-19 patients

ACEI/ARBs do not induce in-hospital mortality in COVID-19 patients

Alpha blockers in CKD patients cardioprotective but may accelerate disease progression

Alpha blockers in CKD patients cardioprotective but may accelerate disease progression

Reproductive health of young women linked to CVD in later life

Reproductive health of young women linked to CVD in later life

Plant protein intake tied to lower all-cause, CVD mortality risk

Plant protein intake tied to lower all-cause, CVD mortality risk

Empagliflozin: Another SGLT-2i in HFrEF armamentarium

Empagliflozin: Another SGLT-2i in HFrEF armamentarium

DASH diet: Best nonpharmacological intervention for hypertension

DASH diet: Best nonpharmacological intervention for hypertension